Kristen Yen - Jan 21, 2025 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Officer title: Senior Vice President, Clinical Operations
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Jan 21, 2025
Transactions value $
$0
Form type
4
Date filed
1/23/2025, 04:29 PM
Previous filing
Jan 6, 2025
Next filing
Mar 31, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award $0 +6.4K +8.35% $0.00 83K Jan 21, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Award $0 +13.8K $0.00 13.8K Jan 21, 2025 Common Stock 13.8K $49.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on each annual anniversary of December 15, 2024, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
F2 Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F3 1/48th of the shares subject to the option shall vest on February 1, 2025 and 1/48th of the remaining shares subject to the option shall vest on each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.

Remarks:

Officer title: Senior Vice President, Clinical Operations